This entry has been replaced by an amended Lobbying Activity Report:
5189-28847
|
Designated Filer name:
|
Beatriz Grigsby-Larson
|
|
Client:
|
Vertex Pharmaceuticals (Canada) Incorporated
|
|
Associated registration:
|
9545-5189-1
|
|
Lobbying Activity date:
|
2023-08-22
|
|
Arranged a meeting:
|
Yes
|
|
Posted date:
|
2023-09-15
|
|
Senior Public Office Holders who were lobbied in this activity:
|
Jack Garnier,
Ministerial Advisor
Jobs, Economic Development and Innovation
|
| |
Subject Matter of the Lobbying Activity
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
• Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
• Engagement on issues related to access to medicines for Rare Diseases.
|
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Health, Intellectual Property, Science and Technology, Taxation and Finance
|
|
| |
|
Lobbying Activity Report amended on:
|
2023-09-12 previous entry:
5189-28435
|
|
Reason for amendment:
|
Terry Harrison could no longer make the meeting and Jack Garnier will be taking the meeting instead.
|
| |
|
Lobbying Activity Report replaced on:
|
2023-09-15
amended entry:
5189-28847
|